Description: The objective of the SPCCT project is to develop and validate a widely accessible, new quantitative and analytical in vivo imaging technology
For an improved detection and monitoring of cardiovascular and neurovascular diseases. The objective of the SPCCT project is to develop and validate a widely accessible, new quantitative and analytical in vivo imaging technology combining Spectral Photon Counting CT and contrast agents, to accurately and early detect, characterize and monitor neurovascular and cardiovascular disease.
*Video of a 3D volume rendering from an acquisition with the Spectral photon counting CT.
This project has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 668142.